MedPath

Combined Neuromodulation and Cognitive Training for Post-mTBI Depression

Not Applicable
Recruiting
Conditions
Concussion, Brain
Depression
Mild Traumatic Brain Injury
Interventions
Device: iTBS
Device: sham iTBS
Behavioral: Personalized, Augmented Cognitive Training (PACT)
Registration Number
NCT05682677
Lead Sponsor
University of California, San Diego
Brief Summary

The primary goal of this clinical trial is to evaluate whether Personalized Augmented Cognitive Training (PACT) plus intermittent theta burst stimulation (iTBS) is effective for treating depression in Service Members, Veterans, and civilians who have sustained a mild TBI. Participants will receive PACT plus 20 sessions of iTBS or sham iTBS over 4 weeks. Assessments will occur at baseline, 2 weeks, 4 weeks, and 8 weeks. Researchers will compare the PACT+iTBS group to the PACT+sham iTBS group to see if PACT+iTBS is associated with more depression improvement.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Male or female
  2. All racial and ethnic groups
  3. Ages 18 to 65
  4. Military service members receiving treatment at NMCSD or civilians receiving treatment at UCSD Health
  5. History of mild TBI (as defined by the DoD/VA criteria used in conjunction with the OSU TBI-ID method) over 3 months prior to study entry
  6. Meets criteria for current Major Depressive Episode within the context of Major Depressive Disorder, per MINI
  7. Score of 18 or higher on the HAMD-17, indicating moderate to severe depressive symptoms
  8. Stable on psychiatric medications for 6 weeks, with no changes to psychiatric medications expected during the study period
  9. No contraindications to TMS (passes the TMS Adult Safety Screening questionnaire)
  10. No contraindications to MRI (passes MRI safety screening questionnaire)
  11. Able to commit to the treatment schedule
  12. Able to complete assessment procedures in English
  13. Intact decision-making capacity and ability to provide voluntary informed consent
Exclusion Criteria
  1. History of moderate, severe, or penetrating TBI
  2. History of other neurological condition unrelated to TBI, including but not limited to: conditions associated with increased intracranial pressure; space occupying brain lesions; cerebral aneurysm; stroke; transient ischemic attack within past two years; Parkinson's disease; Huntington's disease; dementia; multiple sclerosis; history of brain surgery; epilepsy; seizure except those therapeutically induced by electroconvulsive therapy (ECT) or a febrile seizure of infancy
  3. Implanted medical devices including cardiac pacemaker, medication pump, aneurysm clip, shunt, stimulator, cochlear implant, electrodes, or any other metal object within or near the head (excluding the mouth) that cannot be safely removed
  4. Active manic or psychotic illness per MINI
  5. Current substance use disorder per MINI
  6. Current active suicidal or homicidal ideation
  7. Pregnant or intending to become pregnant within the study period; breastfeeding
  8. Other sensory conditions or illnesses precluding participation in assessments or treatment
  9. Current dose of lorazepam 2 mg or greater daily (or benzodiazepine equivalent) or any anticonvulsant due to the potential to limit iTBS efficacy
  10. Taking medication that lowers seizure threshold
  11. Previous failed treatment with rTMS, iTBS, or ECT
  12. Completed >4 sessions of cognitive rehabilitation within the last 3 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PACT+iTBSPersonalized, Augmented Cognitive Training (PACT)Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + intermittent theta burst stimulation (iTBS; 20 sessions over 4 weeks)
PACT+iTBSiTBSPersonalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + intermittent theta burst stimulation (iTBS; 20 sessions over 4 weeks)
PACT+sham iTBSPersonalized, Augmented Cognitive Training (PACT)Personalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + sham intermittent theta burst stimulation (sham iTBS; 20 sessions over 4 weeks)
PACT+sham iTBSsham iTBSPersonalized, Augmented Cognitive Training (PACT; 6 sessions over 4 weeks) + sham intermittent theta burst stimulation (sham iTBS; 20 sessions over 4 weeks)
Primary Outcome Measures
NameTimeMethod
Hamilton Rating Scale for Depressionchange over 8 weeks
Secondary Outcome Measures
NameTimeMethod
WHO Disability Assessment Schedulechange over 8 weeks
Glasgow Outcome Scale - Extendedchange over 8 weeks
Patient Global Impression of Changerating at 8 weeks

This measure asks the participant to rate their status since the start of the study from 1 (very much improved) to 7 (very much worse)

Traumatic Brain Injury Quality of Lifechange over 8 weeks

The Traumatic Brain Injury Quality of Life The Traumatic Brain Injury Quality of Life measurement system (TBI-QOL) is a TBI-specific extension of the NIH PROMIS and Neuro-QoL measures that includes 20 items measuring physical, emotional, social, and cognitive domains

D-KEFS Trail Making Testchange over 8 weeks
D-KEFS Color Word Interference Testchange over 8 weeks
UCSD Performance-Based Skills Assessment-Briefchange over 8 weeks

The UCSD Performance-Based Skills Assessment-Brief is a performance-based measure that uses role play scenarios to assess capacity for financial and communication tasks.

Patient Health Questionnaire-9change over 8 weeks
Neurobehavioral Symptom Inventorychange over 8 weeks
PTSD Checklist for DSM-5change over 8 weeks
Headache Impact Testchange over 8 weeks
Pittsburgh Sleep Quality Indexchange over 8 weeks
Hopkins Verbal Learning Test - Revisedchange over 8 weeks
WAIS-IV Processing Speedchange over 8 weeks
PROMIS Cognitive Function Abilities Short Formchange over 8 weeks
WMS-IV Digit Spanchange over 8 weeks

Trial Locations

Locations (1)

UCSD

🇺🇸

La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath